Apr 19 (Kyodo) - A panel of experts at Japan's health ministry approved Monday the use of a COVID-19 vaccine developed by the U.S. biotechnology firm Novavax Inc.
The ministry plans to give the green light at an early date for the use of what will be the fourth COVID-19 vaccine available in Japan. It will be produced and distributed by Takeda Pharmaceutical Co. ...continue reading